Comparison of Iqwig and G-Ba Benefit Ratings in Oncology

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.08.1758
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pcn315 - Impact of Pro Data on Iqwig Benefit Ratings in Oncology

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Ht8 - Does Iqwig Matter? Frequency of Divergent Opinions Between Iqwig and the G-Ba

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Methods Used to Measure Patient Preferences in Psoriasis Treatments – An Overview With Regards to the German Iqwig and G-Ba

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Iqwig Early Benefit Assessments of Type 2 Diabetes Therapies

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Pcn229 - Comparison of Sickness Benefit and Sick Leave Duration in Oncology Across Countries

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Clinical Trials in Oncology and Defining Benefit

Oncologist
Cancer ResearchMedicineOncology
2017English

Analysis of the G-Ba Decision-Making Criteria on the Benefit Assessment of Diabetes Treatments: Is Cost an Influencing Criterion?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Liposuktion Bei Lipödem – Entscheidung Des G-Ba

Phlebologie
Cardiovascular MedicineCardiology
2019English

IQWiG Sieht Zusatznutzen

DNP - Der Neurologe und Psychiater
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy